5 NYSE Healthcare Stocks With The Highest ROI - Edwards Lifesciences (NYSE:EW), Novo Nordisk (NYSE:NVO)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Below are the top NYSE stocks in the healthcare sector in terms of return on investment.The trailing-twelve-month return on investment at Novo Nordisk A/S (ADR)

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NYSE: NVO) is 65.50 percent. Novo Nordisk's revenue for the same period is $14.00 billion.The trailing-twelve-month return on investment at InVitae Corp (NYSE: NVTA) is 59.20 percent. InVitae's revenue for the same period is $2.70 million.The trailing-twelve-month return on investment at USANA Health Sciences, Inc. (NYSE: USNA) is 33.50 percent. USANA Health Sciences' revenue for the same period is $827.40 million.The trailing-twelve-month return on investment at

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is 30.40 percent. Taro Pharmaceutical's revenue for the same period is $862.90 million.The trailing-twelve-month return on investment at Edwards Lifesciences Corp (NYSE: EW) is 29.10 percent. Edwards Lifesciences' revenue for the same period is $2.39 billion.